Showing 1 to 8 of 8 entries
  • «
  • 1
  • »
BUY
A headwind is that it's a small-cap which the market is not buying now. Management team has a great track record. From June 2021, they've grown the company from $10 million of annual run rate revenue to $90 million (after some acquisitions). More acquisitions and organic growth lie ahead. They're profitable. It's his largest position. He sees shares going much higher.
Healthcare
TOP PICK
Has also been a past pick. When it went public just over a year ago it had $16 million in revenue which should become $70 million by year end with acquisitions and 30% organic growth. Will apply to NASDAQ when it gets to $100 revenue next year. The chairman was in the same business with DJ global which over 6 years gained 10 times. There is lots of runway to buy a business and increase cash flow. Therefore no short-term need for capital raises. Trades at 1X revenue. Buy 2 Hold 0 Sell 0 (Analysts’ price target is $2.50)
Healthcare
TOP PICK
Its IPO was just over a year ago. Its CEO built up another company and sold it for a ten-fold gain. He is doing the same thing through organic growth and acquisitions. It is trading at 1X revenue but is growing fast so should be 5 to 8X revenue. It is one of his bigger positions. In 2 to 5 years it should hit the radar screen of investors and will probably be sold when it reaches a certain size. Buy 2 Hold 0 Sell 0 (Analysts’ price target is $2.50)
Healthcare
PAST TOP PICK
(A Top Pick Jun 29/21, Down 32%) Revenues jumped 100%, earnings up 140%. CEO delivered. Pullback is surprising. Valuation is much better now.
Healthcare
TOP PICK

Believes management team is excellent. Company growing organically with a mix of M&A. Trading at 1.2x sales (peers trade at 4-8x sales). Expecting share price to rise significantly.

Healthcare
BUY
Non-hospital surgical and rehab equipment. Will grow both organically and by acquisition. Acquisitions have been delayed. Hit estimated revenue number, and this should continue. Obtained financing. Pipeline of deals. Earnings will be lumpy. Likes management. If it weren't too small, he'd make it a Top Pick.
Healthcare
BUY
Continue to execute. Waiting for them to integrate acquisitions. Tremendous respect for the Chairman, as he's very picky on acquisitions. Bodes well for long-term success. As they grow market cap and show up on investors' radar, stock should close valuation gap with peers.
Healthcare
TOP PICK
No price target A new company. The CEO comes from an orthotics company that he grew from $100 million to $600 million over six years until he sold it. Non-surgical devices have IP protection. They make small acquisitions and are talking to 50 small companies before they close these deals. He expects $55 revenues, but bigger deals will push that to $75-80 million. Trades at 1.2x revenues vs. peers' 4.5x-18x. Will grow by acquisition and organically as they expand into Europe.
Healthcare
Showing 1 to 8 of 8 entries
  • «
  • 1
  • »

Salona Global Medical Device(SGMD-X) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 4

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 4

Stockchase rating for Salona Global Medical Device is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Salona Global Medical Device(SGMD-X) Frequently Asked Questions

What is Salona Global Medical Device stock symbol?

Salona Global Medical Device is a Canadian stock, trading under the symbol SGMD-X on the TSX Venture Exchange (SGMD-CV). It is usually referred to as TSXV:SGMD or SGMD-X

Is Salona Global Medical Device a buy or a sell?

In the last year, 4 stock analysts published opinions about SGMD-X. 4 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Salona Global Medical Device.

Is Salona Global Medical Device a good investment or a top pick?

Salona Global Medical Device was recommended as a Top Pick by on . Read the latest stock experts ratings for Salona Global Medical Device.

Why is Salona Global Medical Device stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Salona Global Medical Device worth watching?

4 stock analysts on Stockchase covered Salona Global Medical Device In the last year. It is a trending stock that is worth watching.

What is Salona Global Medical Device stock price?

On 2022-09-29, Salona Global Medical Device (SGMD-X) stock closed at a price of $0.59.